Q1 2019 Agios Pharmaceuticals Inc Earnings Call Transcript
Good morning, and welcome to Agios' First Quarter 2019 Conference Call. (Operator Instructions) Please be advised this call is being recorded at Agios' request.
I would now like to turn the call over to Kendra Adams, Vice President, External Communications and Investor Relations.
Thank you, operator. Good morning, everyone, and welcome to Agios' First Quarter 2019 Conference Call. You can access slides for today's call by going to the Investors section of our website, agios.com.
With me on the call today are Dr. Jackie Fouse, our Chief Executive Officer, who will review key business updates, including TIBSOVO commercial performance; Dr. Chris Bowden, our Chief Medical Officer, who will highlight our clinical development progress; and Andrew Hirsch, our Chief Financial officer, who will summarize our first quarter 2019 financial results. Dr. Scott Biller, our Chief Scientific Officer will also be available for Q&A.
Before we get started, I would
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |